1. Home
  2. SMTI vs AQST Comparison

SMTI vs AQST Comparison

Compare SMTI & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMTI
  • AQST
  • Stock Information
  • Founded
  • SMTI 1982
  • AQST 2004
  • Country
  • SMTI United States
  • AQST United States
  • Employees
  • SMTI 108
  • AQST N/A
  • Industry
  • SMTI Medical/Dental Instruments
  • AQST Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMTI Health Care
  • AQST Health Care
  • Exchange
  • SMTI Nasdaq
  • AQST Nasdaq
  • Market Cap
  • SMTI 297.2M
  • AQST 274.4M
  • IPO Year
  • SMTI N/A
  • AQST 2018
  • Fundamental
  • Price
  • SMTI $33.94
  • AQST $3.09
  • Analyst Decision
  • SMTI Strong Buy
  • AQST Strong Buy
  • Analyst Count
  • SMTI 2
  • AQST 7
  • Target Price
  • SMTI $47.00
  • AQST $10.57
  • AVG Volume (30 Days)
  • SMTI 22.3K
  • AQST 1.3M
  • Earning Date
  • SMTI 05-12-2025
  • AQST 03-05-2025
  • Dividend Yield
  • SMTI N/A
  • AQST N/A
  • EPS Growth
  • SMTI N/A
  • AQST N/A
  • EPS
  • SMTI N/A
  • AQST N/A
  • Revenue
  • SMTI $78,056,873.00
  • AQST $57,561,000.00
  • Revenue This Year
  • SMTI $35.26
  • AQST N/A
  • Revenue Next Year
  • SMTI $20.79
  • AQST $35.72
  • P/E Ratio
  • SMTI N/A
  • AQST N/A
  • Revenue Growth
  • SMTI 24.66
  • AQST 13.80
  • 52 Week Low
  • SMTI $26.00
  • AQST $2.24
  • 52 Week High
  • SMTI $39.08
  • AQST $5.80
  • Technical
  • Relative Strength Index (RSI)
  • SMTI 51.76
  • AQST 54.55
  • Support Level
  • SMTI $30.81
  • AQST $2.71
  • Resistance Level
  • SMTI $32.90
  • AQST $2.91
  • Average True Range (ATR)
  • SMTI 1.43
  • AQST 0.20
  • MACD
  • SMTI 0.24
  • AQST 0.05
  • Stochastic Oscillator
  • SMTI 72.27
  • AQST 95.07

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Share on Social Networks: